OptimizeRx (NASDAQ:OPRX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
OptimizeRx beat estimated earnings by 10.0%, reporting an EPS of $0.22 versus an estimate of $0.2.
Revenue was up $3.89 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.04 which was followed by a 0.05% drop in the share price the next day.
Here's a look at OptimizeRx's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.13 | 0.07 | 0.01 | 0.15 |
| EPS Actual | 0.09 | 0.10 | 0.03 | 0.16 |
| Revenue Estimate | 15.06M | 12.45M | 10.47M | 16.02M |
| Revenue Actual | 16.12M | 13.63M | 11.23M | 16.43M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
